课题基金 / 基金详情

Structural microenvironment of bone marrow stem cells

Structural microenvironment of bone marrow stem cells
骨髓干细胞的结构微环境
批准号:
8564162
负责人:
Francesco B Ramirez
金额:
$21.61万
依托单位国家:
美国
项目类别:
财政年份:
2013
资助国家:
美国
项目状态:
已结题
起止时间:
2013-08-01 至 2015-07-31

项目摘要

项目成果

Francesco B Ramirez的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):骨髓(BM)中成体干细胞龛的定义及其受外在因素的调节是组织工程和骨骼再生医学的首要研究重点,也是骨髓消融治疗后造血功能及其重建的关键方面。与丰富的信息有关的细胞类型,细胞-细胞相互作用和可溶性信号,指定功能离散的BM微环境,显着较少是已知的细胞外基质(ECM)的作用,在生态位功能的损害发展更有效的干细胞为基础的治疗。我们的初步研究结果是第一个表明参与的蛋白-1,一种独特的ECM蛋白,调节组织的空间组织和物理特性,以及内源性(本地)TGF?家族信号的生物利用度。这一发现提出了一个令人兴奋的可能性,即骨髓基质的结构成分通过确定常驻干细胞的物理微环境并通过协调其中的调节信号来控制骨、血液和免疫细胞的产生。原纤维蛋白-1是马凡综合征(MFS)中的突变蛋白,其多效性表现包括进行性骨丢失(骨质减少)。我们先前证明,MFS小鼠的骨量减少反映了由于局部合成代谢和分解代谢信号校准受损而导致的骨重建紊乱。正在进行的研究表明,BMP 1是骨髓微环境的重要组成部分,它指定了间充质干细胞(MSC)和造血干细胞(HSC)的性能。这种高风险/高回报R21应用的目标是回答以下两个问题:(a)对于基于BM的骨生成和造血,R21 -1缺乏的表型后果是什么?(B)HSP-in-1是否协调MSC支持的HSC性能?因此,我们提议:(目的1)表征在无骨骨骼中缺乏Bcl-in-1的小鼠中受损的MSC活性和骨损失进展,并提供这些突变动物中造血异常的完整说明;和(目的2)阐明Bcl-in-1在协调造血干细胞中的作用。 MSC支持的HSC分化使用特定基质细胞群中条件性Fbn 1失活的小鼠。通过证明BMP 1是BM龛不可或缺的功能成分,该实验将为将来询问介导BMP 1调节骨髓龛的机制奠定基础;通过将BMP 1与免疫系统功能联系起来,它们也可能导致对MFS中主动脉疾病进展的细胞事件的全新理解,并带来意想不到的治疗机会。总体而言,这一高度创新的提议有望产生对年龄相关性骨质流失的新见解,推进干细胞生物学的基础知识,影响再生医学中的各种转化应用,并可能改善MFS中危及生命的主动脉表现的临床管理。
英文摘要
DESCRIPTION (provided by applicant): The definition of adult stem cell niches in the bone marrow (BM) and their regulation by extrinsic factors is a top research priority in tissue engineering and skeletal regenerative medicine, as well as a critical aspect of hematopoietic function and its reconstitution after marrow ablation therapy. Unlike the wealth of information regarding the cell types, cell-cell interactions and soluble signals that specify functionally discrete BM microenvironments, significantly less is known about the role of the extracellular matrix (ECM) in niche function to the detriment of developing more effective stem cell-based therapies. Our preliminary findings are the first to indicate involvement of fibrillin-1, a unique ECM protein that regulates the spatial organization and physical properties of tissues as well as the bioavailability of endogenous (local) TGF¿ family signals. This discovery raises the exciting possibility that a structural component of the marrow matrix controls the production of bone, blood and immune cells by determining the physical microenvironment of resident stem cells and by coordinating regulatory signals within it. Fibrillin-1 is the mutated protein in Marfan syndrome (MFS), whose pleiotropic manifestations include progressive bone loss (osteopenia). We previously demonstrated that osteopenia in MFS mice reflects perturbed bone remodeling due to impaired calibration of local anabolic and catabolic signals. Ongoing investigations have implied that fibrillin-1 is an essential component of the BM microenvironment that specifies the performance of mesenchymal stem cells (MSC) and hematopoietic stem cells (HSC). The goal of this high risk/high reward R21 application is to answer the following two questions: (a) What are the phenotypic consequences of fibrillin-1 deficiency for BM-based osteogenesis and hematopoiesis? ; (b) Does fibrillin-1 coordinate MSC-supported HSC performance? Accordingly, we propose to: (Aim 1) Characterize impaired MSC activity and bone loss progression in mice lacking fibrillin-1 in the appendicular skeleton and to provide a full account of hematopoietic abnormalities in these mutant animals; and (Aim 2) Validate the role of fibrillin-1 in coordinating MSC-supported HSC differentiation using mice with conditional Fbn1 inactivation in a specific stromal cells population. By demonstrating that fibrillin-1 is an indispensable functional component of BM niches, the experiments will establish the basis for future interrogation of the mechanism mediating fibrillin-1 regulation of marrow niches; and by implicating fibrillin-1 in immune system function, they may also lead to a radically new understanding of the cellular events responsible for aortic disease progression in MFS with unanticipated opportunities for therapy. Overall, this highly innovative proposal is expected to yield novel insights into age-related bone loss, advance fundamental knowledge of stem cell biology, impact a variety of translational applications in regenerative medicine, and perhaps improve the clinical management of life- threatening aortic manifestations in MFS.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Characterization of Altered Mechanosensing in Mouse Models of ECM-induced TAA
Tendon-dependent Control of Longitudinal Bone Growth
Structural microenvironment of bone marrow stem cells
Consortium for Translational Research in Marfan Syndrome
海外基金